An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case
Abstract In addition to the psychological depressive phenotype, major depressive disorder (MDD) patients are also associated with underlying immune dysregulation that correlates with metabolic syndrome prevalent in depressive patients. A robust integrative analysis of biological pathways underlying...
Guardado en:
Autores principales: | Anup Mammen Oommen, Stephen Cunningham, Páraic S. O’Súilleabháin, Brian M. Hughes, Lokesh Joshi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7eae96b9cf37442c9578d13b6926dd7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009) -
Gene expression-based biological test for major depressive disorder: an advanced study
por: Watanabe S, et al.
Publicado: (2017) -
Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
por: Tsutsumi T, et al.
Publicado: (2016) -
Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
por: Sharareh Parami, et al.
Publicado: (2021) -
Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Hyunju Lee, et al.
Publicado: (2021)